(Bloomberg) — Merck & Co. agreed to buy Acceleron Pharma Inc. for about $11.5 billion, building out its portfolio of therapies to treat rare diseases.
Most Read from Bloomberg
Acceleron shareh… [+2231 chars]
Merck to Buy Rare-Disease Firm Acceleron for $11.5 Billion – Yahoo Finance